CYP3A4 mediated in vitro metabolism of vinflunine in human liver microsomes

被引:0
作者
Xiao-ping ZHAO Jiao ZHONG Xiao-quan LIU~2 Guang-ji WANG Key Laboratory of Drug Metabolism and Pharmacokinetics
机构
关键词
vinflunine; metabolism; CYP3A4; liver microsomes;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
Aim:To study the metabolism of vinflunine and the effects of selective cyto-chrome P-450(CYP450)inhibitors on the metabolism of vinflunine in human livermicrosomes.Methods:Individual selective CYP450 inhibitors were used to inves-tigate their effects on the metabolism of vinflunine and the principal CYP450 isoforminvolved in the formation of metabolites M1and M2in human liver microsomes.Results:Vinflunine was rapidly metabolized to 2 metabolites:M1and M2in humanliver microsomes.M1and M2were tentatively presumed to be the N-oxide metabo-lite or hydroxylated metabolite and epoxide metabolite of vinflunine,respectively.Ketoconazole uncompetitively inhibited the formation of M1,and competitivelyinhibited the formation of M2,while α-naphthoflavone,sulfaphenazole,diethyldithiocarbamate,tranylcypromine and quinidine bad little or no inhibitory effecton the formation of M1and M2.Conclusion:Vinflunine is rapidly metabolized inhuman liver microsomes,and CYP3A4 is the major human CYP450 involved in themetabolism of vinflunine.
引用
收藏
页码:118 / 124
页数:7
相关论文
共 9 条
  • [1] 西尼地平在人肝微粒体内代谢及代谢抑制(英文)
    柳晓泉
    赵阳
    李丹
    钱之玉
    王广基
    [J]. ActaPharmacologicaSinica, 2003, (03) : 73 - 78
  • [2] Determination of vinflunine in rat plasma by liquid chromatography–electrospray ionization mass spectrometry for a pharmacokinetic study[J] . Xiaoping Zhao,Xiaoquan Liu,Yongsheng Wang,Jiao Zhong,Yan Chen,Guangji Wang.Journal of Pharmaceutical and Biomedical Analysis . 2006 (3)
  • [3] New sensitive liquid chromatography method coupled with tandem mass spectrometric detection for the clinical analysis of vinorelbine and its metabolites in blood, plasma, urine and faeces[J] . J.C Van Heugen,J De Graeve,G Zorza,C Puozzo.Journal of Chromatography A . 2001 (1)
  • [4] Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts[J] . B.T Hill,H.-H Fiebig,W.R Waud,M.-F Poupon,F Colpaert,A Kruczynski.European Journal of Cancer . 1999 (3)
  • [5] Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid[J] . Anna Kruczynski,Jean-Marc Barret,Chantal Etiévant,Francis Colpaert,Jacques Fahy,Bridget T. Hill.Biochemical Pharmacology . 1998 (5)
  • [6] Vinflunine (20′,20′-difluoro- 3′,4′-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro[J] . Chantal Etievant,Jean-Marc Barret,Anna Kruczynski,Dominique Perrin,Bridget T. Hill.Investigational New Drugs . 1998 (1)
  • [7] Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid[J] . Anna Kruczynski,Francis Colpaert,Jean-Pierre Tarayre,Pierre Mouillard,Jacques Fahy,Bridget T. Hill.Cancer Chemotherapy and Pharmacology . 1998 (6)
  • [8] Optimising treatment outcomes: a review of current management strategies in first-line chemotherapy of metastatic breast cancer[J] . J. Crown.European Journal of Cancer . 1997
  • [9] Vinorelbine: an overview[J] . S.A. Johnson,P. Harper,G.N. Hortobagyi,P. Pouillart.Cancer Treatment Reviews . 1996 (2)